Durable Response to Enfortumab Vedotin Compared to Re-challenging Chemotherapy in Metastatic Urothelial Carcinoma After Checkpoint Inhibitors
Taizo Uchimoto(Osaka University of Pharmaceutical Sciences), Haruhito Azuma(Osaka University of Pharmaceutical Sciences), Takuya Tsujino(Osaka University of Pharmaceutical Sciences), Atsuhiko Yoshizawa(Fujita Health University Hospital), Mamoru Hashimoto(University of Pittsburgh), Fumihiko Urabe(Jikei University School of Medicine), Kosuke Iwatani(Jikei University School of Medicine), Wataru Fukuokaya(Jikei University School of Medicine), Jun Miki(Jikei University School of Medicine), Keiichiro Mori(Jikei University School of Medicine), Kazuki Nishimura(Osaka University of Pharmaceutical Sciences), Kyosuke Nishio(Osaka University of Pharmaceutical Sciences), Takafumi Yanagisawa(Jikei University School of Medicine), Takahiro Adachi(Tokyo Medical University), Ko Nakamura, Shutaro Yamamoto, Hirotsugu Uemura(Kindai University), Takuya Higashio(Osaka University of Pharmaceutical Sciences), Masanobu Saruta(Fujita Health University), Yoshio Ohno(Tokyo Medical University), Teruo Inamoto(Hamamatsu University), Takeshi Hashimoto(Tokyo Medical University), Kazumasa Komura(Kawasaki Medical School), Kazutoshi Fujita(Kindai University), Ryoichi Shiroki(Fujita Health University), Takahiro Kimura(Jikei University School of Medicine), Takuya Matsuda(Nagoya University), Shuya Tsuchida(Osaka University of Pharmaceutical Sciences), Tatsuo Fukushima(Osaka University of Pharmaceutical Sciences), Kiyoshi Takahara(Osaka Medical and Pharmaceutical University), Shunsuke Tsuduki(Jikei University School of Medicine), Yosuke Hirasawa(Cedars-Sinai Medical Center)
Cited by 9
Related Papers
Extracellular vesicles as biomarkers and therapeutic targets for cancer
|American Journal of Physiology-Cell Physiology|2019|412
Circulating miRNA panels for specific and early detection in bladder cancer
|Cancer Science|2018|282
Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy
|eLife|2018|191
Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection.
|Proceedings of the National Academy of Sciences|1996|167
Large-scale Circulating microRNA Profiling for the Liquid Biopsy of Prostate Cancer
|Clinical Cancer Research|2019|129